Free Trial

Synthomer (LON:SYNT) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?

Synthomer logo with Basic Materials background

Shares of Synthomer plc (LON:SYNT - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 112.64 ($1.49) and traded as low as GBX 90.30 ($1.19). Synthomer shares last traded at GBX 90.30 ($1.19), with a volume of 663,987 shares trading hands.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Synthomer from GBX 140 ($1.85) to GBX 115 ($1.52) and set a "hold" rating on the stock in a research report on Wednesday.

Read Our Latest Analysis on SYNT

Synthomer Price Performance

The business's 50 day moving average price is GBX 102.98 and its 200 day moving average price is GBX 112.07. The stock has a market capitalization of £131.18 million, a P/E ratio of -1.60, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The company has a debt-to-equity ratio of 78.27, a current ratio of 1.90 and a quick ratio of 0.97.

Insider Transactions at Synthomer

In related news, insider Janet E. Ashdown purchased 19,920 shares of the business's stock in a transaction dated Thursday, July 3rd. The shares were purchased at an average cost of GBX 99 ($1.31) per share, for a total transaction of £19,720.80 ($26,051.25). 28.00% of the stock is currently owned by insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Recommended Stories

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines